HELLP Syndrome Clinical Trial
Official title:
Dexamethasone Efficacy in HELLP I Syndrome, a Multicentric, Double-blind, Placebo-controlled, Randomized Clinical Trial
The purpose of this study is to determine the efficacy of dexamethasone for treatment of HELLP I (hemolysis, elevated liver enzymes and low platelet count) syndrome.
Treatment of HELLP syndrome usually is restricted to measures of support and treatment of complications. In 2005, in a subgroup analysis we showed that, among patients with HELLP 1, there were a shorter average time to platelet recovery and less duration of hospitalization in women who received dexamethasone therapy, however the importance of this finding is diminished because this was an unplanned analysis and the severity of the disease was not taken into account at randomization. ;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03605511 -
TTP and aHUS in Complicated Pregnancies
|
||
Completed |
NCT02911701 -
Effect of Acetaminophen on Postpartum Blood Pressure Control in Preeclampsia With Severe Features
|
Phase 4 | |
Recruiting |
NCT02247297 -
Pancreatic Stone Protein (PSP) in Pregnant Women
|
||
Terminated |
NCT04725812 -
Complement Regulation to Undo Systemic Harm in Preeclampsia
|
Phase 2 | |
Recruiting |
NCT02020174 -
The Preeclampsia Registry
|
||
Recruiting |
NCT06377878 -
The Preeclampsia Registry
|
||
Recruiting |
NCT02920593 -
A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy
|
Phase 4 | |
Recruiting |
NCT05500989 -
PlacEntal Acute Atherosis RefLecting Subclinical Atherosclerosis
|
||
Completed |
NCT04216706 -
Early Vascular Adjustments to Prevent Preeclampsia
|
||
Recruiting |
NCT03834285 -
Liver Disease in Pregnancy
|
||
Completed |
NCT00000534 -
Calcium for Pre-Eclampsia Prevention (CPEP)
|
Phase 3 | |
Recruiting |
NCT02807324 -
Women Specific Cardiac Recovery After Preeclampsia
|
||
Completed |
NCT01736826 -
Free DNA and Nucleosome Concentrations in Pathological Pregnancies
|
||
Terminated |
NCT00711841 -
Effectivity of Postpartum Dexamethasone for Women With Class I HELLP Syndrome
|
Phase 4 | |
Completed |
NCT00097110 -
RCT of Antioxidant Therapy to Prevent Preeclampsia in Brazil
|
Phase 3 | |
Completed |
NCT03715647 -
Correlation of Survival in Puerperae by Electrical Impedance Tomography
|
||
Completed |
NCT03455387 -
Evaluation of the Serum Markers sFLt1 and PlGF for the Prediction of the Complications of the Placental Vascular Pathologies in the 3rd Quarter of the Pregnancy.
|
||
Completed |
NCT03232359 -
Immature Platelet Fraction as a Promising Biomarker in Prediction Outcome of HELLP Syndrome
|
N/A | |
Completed |
NCT03246542 -
Promising Bimarker Prediction of Outcome of HELLP Syndrome.
|
N/A | |
Not yet recruiting |
NCT06452498 -
Preeclampsia Intervention Netherlands
|
Phase 3 |